milrinone has been researched along with Mucopolysaccharidosis I in 1 studies
Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe mucopolysaccharidosis type I, (MPS IH) is a rare inherited lysosomal disorder resulting in progressive storage of proteoglycans (GAGs) in central nervous system and somatic tissues and, if left untreated, causing death within the first decade of life." | 1.91 | Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function. ( Braunlin, E; Elsbecker, SA; Gupta, AO; Lund, TC; Orchard, PJ; Pillai, NR, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pillai, NR | 1 |
| Elsbecker, SA | 1 |
| Gupta, AO | 1 |
| Lund, TC | 1 |
| Orchard, PJ | 1 |
| Braunlin, E | 1 |
1 other study available for milrinone and Mucopolysaccharidosis I
| Article | Year |
|---|---|
Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.
Topics: Enzyme Replacement Therapy; Heart; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, | 2023 |